{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:39:13Z","timestamp":1793907553833,"version":"4.8.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.metabol.2023.155593","type":"journal-article","created":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T20:56:28Z","timestamp":1684961788000},"page":"155593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Renin-independent aldosteronism and chronic kidney disease in diabetes: Observational and Mendelian randomization analyses"],"prefix":"10.1016","volume":"145","author":[{"given":"Jinbo","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglian","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfeng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilin","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.metabol.2023.155593_bb0005","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJMc2207018","article-title":"Incidence of chronic kidney disease among adults with diabetes, 2015-2020","volume":"387","author":"Tuttle","year":"2022","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.metabol.2023.155593_bb0010","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1053\/j.ajkd.2022.04.016","article-title":"Aldosterone, mineralocorticoid receptor activation, and CKD: a review of evolving treatment paradigms","volume":"80","author":"Epstein","year":"2022","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.metabol.2023.155593_bb0015","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41581-021-00490-8","article-title":"Mineralocorticoid receptor antagonists in diabetic kidney disease - mechanistic and therapeutic effects","volume":"18","author":"Barrera-Chimal","year":"2022","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"10.1016\/j.metabol.2023.155593_bb0020","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1210\/er.2018-00139","article-title":"The expanding spectrum of primary aldosteronism: implications for diagnosis, pathogenesis, and treatment","volume":"39","author":"Vaidya","year":"2018","journal-title":"Endocr Rev"},{"issue":"9","key":"10.1016\/j.metabol.2023.155593_bb0025","doi-asserted-by":"crossref","first-page":"630","DOI":"10.7326\/M17-0882","article-title":"The spectrum of subclinical primary aldosteronism and incident hypertension: a cohort study","volume":"167","author":"Brown","year":"2017","journal-title":"Ann Intern Med"},{"issue":"24","key":"10.1016\/j.metabol.2023.155593_bb0030","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.023082","article-title":"Heightened cardiovascular risk in hypertension associated with renin-independent aldosteronism versus renin-dependent aldosteronism: a collaborative study","volume":"10","author":"Hu","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"38","key":"10.1016\/j.metabol.2023.155593_bb0035","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1093\/eurheartj\/ehac352","article-title":"Aldosterone in chronic kidney disease and renal outcomes","volume":"43","author":"Verma","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.metabol.2023.155593_bb0040","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1471-2369-15-44","article-title":"Aldosterone and glomerular filtration--observations in the general population","volume":"15","author":"Hannemann","year":"2014","journal-title":"BMC Nephrol"},{"issue":"11","key":"10.1016\/j.metabol.2023.155593_bb0045","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1097\/HJH.0b013e32834bbc8a","article-title":"Association of plasma renin activity and aldosterone-renin ratio with prevalence of chronic kidney disease: the Kaiser Permanente Southern California cohort","volume":"29","author":"Sim","year":"2011","journal-title":"J Hypertens"},{"issue":"8","key":"10.1016\/j.metabol.2023.155593_bb0050","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1097\/HJH.0b013e328354f65b","article-title":"Plasma renin activity and the aldosterone-to-renin ratio are associated with the development of chronic kidney disease: the Ohasama Study","volume":"30","author":"Terata","year":"2012","journal-title":"J Hypertens"},{"issue":"1","key":"10.1016\/j.metabol.2023.155593_bb0055","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/ajh\/hpac112","article-title":"Renin: measurements, correlates, and associations with long-term adverse kidney outcomes","volume":"36","author":"Blum","year":"2023","journal-title":"Am J Hypertens"},{"issue":"1","key":"10.1016\/j.metabol.2023.155593_bb0060","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12882-022-02763-1","article-title":"The effect of renin-angiotensin-aldosterone system inhibitors on continuous and binary kidney outcomes in subgroups of patients with diabetes: a meta-analysis of randomized clinical trials","volume":"23","author":"Alsalemi","year":"2022","journal-title":"BMC Nephrol"},{"issue":"4","key":"10.1016\/j.metabol.2023.155593_bb0065","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s13300-022-01236-w","article-title":"A podcast discussing aldosterone and mineralocorticoid receptor antagonists in 2021: a paradigm shift","volume":"13","author":"Epstein","year":"2022","journal-title":"Diabetes Ther"},{"issue":"23","key":"10.1016\/j.metabol.2023.155593_bb0070","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.metabol.2023.155593_bb0075","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1001\/jama.2015.10081","article-title":"Effect of finerenone on albuminuria in patients with diabetic nephropathy: a randomized clinical trial","volume":"314","author":"Bakris","year":"2015","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.metabol.2023.155593_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0265642","article-title":"Efficacy and safety of eplerenone treatment for patients with diabetic nephropathy: a meta-analysis","volume":"17","author":"Hu","year":"2022","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.metabol.2023.155593_bb0085","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.2337\/diacare.28.9.2106","article-title":"Beneficial effects of adding spironolactone to recommended antihypertensive treatment in diabetic nephropathy: a randomized, double-masked, cross-over study","volume":"28","author":"Rossing","year":"2005","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.metabol.2023.155593_bb0090","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1111\/j.1523-1755.2005.00756.x","article-title":"Beneficial impact of spironolactone in diabetic nephropathy","volume":"68","author":"Schjoedt","year":"2005","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.metabol.2023.155593_bb0095","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/sj.ki.5001580","article-title":"Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathy","volume":"70","author":"Schjoedt","year":"2006","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.metabol.2023.155593_bb0100","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/s41591-022-01845-9","article-title":"Parental inflammatory bowel disease and autism in children","volume":"28","author":"Sadik","year":"2022","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.metabol.2023.155593_bb0105","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/s41591-020-0785-8","article-title":"Trans-biobank analysis with 676,000 individuals elucidates the association of polygenic risk scores of complex traits with human lifespan","volume":"26","author":"Sakaue","year":"2020","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.metabol.2023.155593_bb0110","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.2337\/dc16-1025","article-title":"Abdominal obesity is more closely associated with diabetic kidney disease than general obesity","volume":"39","author":"Hu","year":"2016","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.metabol.2023.155593_bb0115","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.2337\/db20-1031","article-title":"Perirenal fat thickness is significantly associated with the risk for development of chronic kidney disease in patients with diabetes","volume":"70","author":"Chen","year":"2021","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.metabol.2023.155593_bb0120","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/1753-0407.12322","article-title":"Combined effects of sex hormone-binding globulin and sex hormones on risk of incident type 2 diabetes","volume":"8","author":"Hu","year":"2016","journal-title":"J Diabetes"},{"issue":"1","key":"10.1016\/j.metabol.2023.155593_bb0125","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/HYPERTENSIONAHA.117.10197","article-title":"Confirmatory tests for the diagnosis of primary aldosteronism: a prospective diagnostic accuracy study","volume":"71","author":"Song","year":"2018","journal-title":"Hypertension"},{"issue":"16","key":"10.1016\/j.metabol.2023.155593_bb0130","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.jacc.2020.02.052","article-title":"Primary aldosteronism in patients in China with recently detected hypertension","volume":"75","author":"Xu","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.metabol.2023.155593_bb0135","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa282","article-title":"Development and validation of criteria for sparing confirmatory tests in diagnosing primary aldosteronism","volume":"105","author":"Wang","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.metabol.2023.155593_bb0140","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/ije\/dym276","article-title":"The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine","volume":"37","author":"Elliott","year":"2008","journal-title":"Int J Epidemiol"},{"issue":"9","key":"10.1016\/j.metabol.2023.155593_bb0145","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.metabol.2023.155593_bb0150","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/HYPERTENSIONAHA.116.07564","article-title":"KCNK3 variants are associated with hyperaldosteronism and hypertension","volume":"68","author":"Manichaikul","year":"2016","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.metabol.2023.155593_bb0155","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1038\/s41467-022-32896-8","article-title":"Identification of risk loci for primary aldosteronism in genome-wide association studies","volume":"13","author":"Le Floch","year":"2022","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.metabol.2023.155593_bb0160","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/HYPERTENSIONAHA.113.02504","article-title":"Diastrophic dysplasia sulfate transporter (SLC26A2) is expressed in the adrenal cortex and regulates aldosterone secretion","volume":"63","author":"Spyroglou","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.metabol.2023.155593_bb0165","doi-asserted-by":"crossref","first-page":"186","DOI":"10.12688\/wellcomeopenres.15555.1","article-title":"Guidelines for performing Mendelian randomization investigations","volume":"4","author":"Burgess","year":"2019","journal-title":"Wellcome Open Res"},{"issue":"7","key":"10.1016\/j.metabol.2023.155593_bb0170","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.2337\/db17-0914","article-title":"A genome-wide association study of diabetic kidney disease in subjects with type 2 diabetes","volume":"67","author":"van Zuydam","year":"2018","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.metabol.2023.155593_bb0175","first-page":"1866","article-title":"Triangulation in aetiological epidemiology","volume":"45","author":"Lawlor","year":"2016","journal-title":"Int J Epidemiol"},{"issue":"1","key":"10.1016\/j.metabol.2023.155593_bb0180","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/EDE.0000000000000559","article-title":"Sensitivity analyses for robust causal inference from Mendelian randomization analyses with multiple genetic variants","volume":"28","author":"Burgess","year":"2017","journal-title":"Epidemiology"},{"issue":"4","key":"10.1016\/j.metabol.2023.155593_bb0185","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1111\/j.1523-1755.2004.00524.x","article-title":"Plasma aldosterone concentration in the patient with diabetes mellitus","volume":"65","author":"Hollenberg","year":"2004","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.metabol.2023.155593_bb0190","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41588-018-0183-z","article-title":"Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations","volume":"50","author":"Khera","year":"2018","journal-title":"Nat Genet"},{"issue":"16","key":"10.1016\/j.metabol.2023.155593_bb0195","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.jacc.2018.07.079","article-title":"Genomic risk prediction of coronary artery disease in 480,000 adults: implications for primary prevention","volume":"72","author":"Inouye","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.metabol.2023.155593_bb0200","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/s41591-022-01767-6","article-title":"Development of a clinical polygenic risk score assay and reporting workflow","volume":"28","author":"Hao","year":"2022","journal-title":"Nat Med"},{"issue":"16","key":"10.1016\/j.metabol.2023.155593_bb0205","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.metabol.2023.155593_bb0210","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S2215-0366(21)00286-8","article-title":"Associations between plasma fatty acid concentrations and schizophrenia: a two-sample Mendelian randomisation study","volume":"8","author":"Jones","year":"2021","journal-title":"Lancet Psychiatry"},{"issue":"4","key":"10.1016\/j.metabol.2023.155593_bb0215","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.biopsych.2022.08.012","article-title":"The relationship of attention-deficit\/hyperactivity disorder with posttraumatic stress disorder: a two-sample Mendelian randomization and population-based sibling comparison study","volume":"93","author":"Wendt","year":"2023","journal-title":"Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.metabol.2023.155593_bb0220","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1161\/HYPERTENSIONAHA.116.07716","article-title":"Preclinical and early clinical profile of a highly selective and potent oral inhibitor of aldosterone synthase (CYP11B2)","volume":"69","author":"Bogman","year":"2017","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.metabol.2023.155593_bb0225","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa2213169","article-title":"Phase 2 trial of Baxdrostat for treatment-resistant hypertension","volume":"388","author":"Freeman","year":"2022","journal-title":"N Engl J Med"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002604952300197X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002604952300197X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:30:47Z","timestamp":1758429047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002604952300197X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":45,"alternative-id":["S002604952300197X"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2023.155593","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renin-independent aldosteronism and chronic kidney disease in diabetes: Observational and Mendelian randomization analyses","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2023.155593","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"155593"}}